Cardiovascular Disease Doctors in Ridgefield, CT Accepting Medicare

2 Cardiovascular Disease doctors found. Showing 1 - 2

Dr. Evan S Levine, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 598 Danbury Rd, Ridgefield, CT 06877 Phone: 917-748-8898

Ronald John Raymond, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 30 Prospect St, Suite 200, Ridgefield, CT 06877 Phone: 203-438-9621    Fax: 203-438-4596

News Archive

Report: Use of indoor tanning beds increases risk of melanoma

Use of indoor tanning beds increases risk of melanoma between twofold and fourfold depending on the device and length of time indoor tanning is used, according to a report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

Over 80% of hospitalized patients suffer more severe pain than necessary

More than 80% of hospitalized patients suffer more severe pain than necessary. This is the conclusion of Christoph Maier (Bochum University Hospital, Bochum, Germany) and his coauthors in their interim report of the Pain-Free Hospital Project ("Schmerzfreies Krankenhaus"), which appears in the current issue of Deutsches -rzteblatt International. The project, which was initiated in 2003, has the goal of improving pain management in hospitals across Germany.

Calcium intake could be used as a prognostic factor for osteoporosis

Measuring a man's daily calcium intake is an effective way of identifying prostate cancer patients with a higher than average risk of osteoporosis, according to the April issue of the urology journal BJU International.

Rett disease progression altered by changing expression of gene

Scientists from the Whitehead Institute for Biomedical Research, Brandeis University and Massachusetts Institute of Technology report in the journal Neuron that increasing levels of brain derived neurotrophic factor (BDNF) alleviates symptoms in a mouse model of the childhood disorder Rett Syndrome.

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

Read more Medical News

› Verified 2 days ago